Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 15;22(1):179.
doi: 10.1186/s12882-021-02384-0.

Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation

Anat Bel-Ange  1 , Shani Zilberman Itskovich  2 , Liana Avivi  3 , Kobi Stav  4 , Shai Efrati  2 , Ilia Beberashvili  5
Affiliations

Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation

Anat Bel-Ange et al. BMC Nephrol. .

Abstract

Background: We tested whether CHA2DS2-VASc and/or HAS-BLED scores better predict ischemic stroke and major bleeding, respectively, than their individual components in maintenance hemodialysis (MHD) patients with atrial fibrillation (AF).

Methods: A retrospective cohort study of a clinical database containing the medical records of 268 MHD patients with non-valvular AF (167 women, mean age 73.4 ± 10.2 years). During the median follow-up of 21.0 (interquartile range, 5.0-44.0) months, 46 (17.2%) ischemic strokes and 24 (9.0%) major bleeding events were reported.

Results: Although CHA2DS2-VASc predicted ischemic stroke risk in the study population (adjusted HR 1.74 with 95% CI 1.23-2.46 for each unit of increase in CHA2DS2-VASc score, and HR of 5.57 with 95% CI 1.88-16.49 for CHA2DS2-VASc score ≥ 6), prior ischemic strokes/transient ischemic attacks (TIAs) were non-inferior in both univariate and multivariate analyses (adjusted HR 8.65 with 95% CI 2.82-26.49). The ROC AUC was larger for the prior ischemic stroke/TIA than for CHA2DS2-VASc. Furthermore, the CHA2DS2-VASc score did not predict future ischemic stroke risks in study participants who did not previously experience ischemic strokes/TIAs (adjusted HR 1.41, 95% CI: 0.84-2.36). The HAS-BLED score and its components did not have predictive abilities in discriminating bleeding risk in the study population.

Conclusions: Previous ischemic strokes are non-inferior for predicting of future ischemic strokes than the complete CHA2DS2-VASc score in MHD patients. CHA2DS2VASc scores are less predictive in MHD patients without histories of CVA/TIA. HAS-BLED scores do not predict major bleeding in MHD patients. These findings should redesign approaches to ischemic stroke risk stratification in MHD patients if future large-scale epidemiological studies confirm them.

Keywords: Bleeding; CHA2DS2-VASc; HAS-BLED; Hemodialysis; Stroke.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow diagram of the study
Fig. 2
Fig. 2
Kaplan–Meier curves for cumulative hazard of ischemic stroke in the study population (n = 268, event n = 46) according to CHA2DS2VASc-score stratified as low-, intermediate- and high-risk groups (a), as low and high-risk groups according to the cut-off value obtained from AUC ROC analysis (b) and according to the history of prior ischemic stroke (c)
Fig. 3
Fig. 3
Kaplan–Meier curves for cumulative hazard of ischemic stroke in the study population without chronic anticoagulation (n = 176, event n = 31) according to CHA2DS2VASc-score stratified as low-, intermediate- and high-risk groups (a), as low and high-risk groups according to the cut-off value obtained from AUC ROC analysis (b) and according to the history of prior ischemic stroke (c)
Fig. 4
Fig. 4
Kaplan–Meier curves for cumulative hazard of ischemic stroke in the study population without past history of ischemic stroke (n = 181, event n = 18) according to CHA2DS2VASc-score stratified as low-, intermediate- and high-risk groups (a) and as low and high-risk groups according to the cut-off value obtained from AUC ROC analysis (b)
Fig. 5
Fig. 5
Kaplan–Meier curves for cumulative hazard of major bleeding in the whole study population (n = 268, event n = 24) (a) and in the study population without chronic anticoagulation (n = 176, event n = 15) (b) according to HAS-BLED score stratified as low-, intermediate- and high-risk groups
See this image and copyright information in PMC

References

    1. Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2011;22(2):349–357. doi: 10.1681/ASN.2010050459. - DOI - PMC - PubMed
    1. Baber U, Howard VJ, Halperin JL, Soliman EZ, Zhang X, McClellan W, Warnock DG, Muntner P. Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for geographic and racial differences in stroke (REGARDS) study. Circ Arrhythm Electrophysiol. 2011;4(1):26–32. doi: 10.1161/CIRCEP.110.957100. - DOI - PMC - PubMed
    1. Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant. 2012;27(10):3816–3822. doi: 10.1093/ndt/gfs416. - DOI - PubMed
    1. Voroneanu L, Ortiz A, Nistor I, Covic A. Atrial fibrillation in chronic kidney disease. Eur J Intern Med. 2016;33:3–13. doi: 10.1016/j.ejim.2016.04.007. - DOI - PubMed
    1. Buiten MS, de Bie MK, Rotmans JI, Gabreëls BA, van Dorp W, Wolterbeek R, Trines SA, Schalij MJ, Jukema JW, Rabelink TJ, van Erven L. The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients. Heart. 2014;100(9):685–690. doi: 10.1136/heartjnl-2013-305417. - DOI - PubMed